Penumbra (NYSE:PEN) specializes in designing, developing, manufacturing, and marketing innovative medical devices. Focused primarily on neuro and peripheral vascular conditions, Penumbra aims to provide healthcare professionals with state-of-the-art tools that enhance patient outcomes. Their operations encompass a wide range of projects from stroke prevention to management of vascular disorders, demonstrating a firm commitment to advancing medical technology. The objective of Penumbra is to continue pioneering solutions that address unmet clinical needs, driving progress in patient care and safety.